---
title: "GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0
json: https://whiteintel.dev/api/public/dossier/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0
identifier: oo:GB-COH-00835139
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-00835139`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0  

## Cross-source identity

The same real-world entity, resolved across sources:

- **GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED** — GLEIF · `lei:5493003EJXH8XA8L9095` — https://whiteintel.dev/entity/4315761f-a609-50d4-ba17-db1b188f1fc3

## Ownership & control

### Owners / controllers

- **GLAXO GROUP LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8
- **Glaxo Group Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340

### Holdings / subsidiaries

- **STEVENAGE BIOSCIENCE CATALYST** (beneficial owner) — 50% — https://whiteintel.dev/entity/647c8573-9445-5bba-b0fc-ceccfbcc39fc
- **STEVENAGE BIOSCIENCE CATALYST** (beneficial owner) — https://whiteintel.dev/entity/647c8573-9445-5bba-b0fc-ceccfbcc39fc

### UBO chain (walk to the ultimate owner)

A **16-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `00835139`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 1965-01-22
- **Registered office:** 79 New Oxford Street, London, WC1A 1DG, United Kingdom
- **SIC:** 72190

### Officers

- WHYTE, Victoria — secretary · British · appointed 2011-02-28
- GURUNLU RUSS, Demet — director · Turkish · appointed 2024-06-25
- KHAVANDI, Kaivan, Dr — director · British · appointed 2024-05-22
- LYNCH, Aidan — director · Irish · appointed 2024-08-20
- PICKERING, Christopher David George — director · British · appointed 2024-05-22
- RIVERS, Graham Paul — director · British · appointed 2023-09-20
- EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED — corporate director · appointed 2001-01-31
- [GLAXO GROUP LIMITED](https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340) — corporate director · appointed 2001-01-31
- BICKNELL, Simon Michael — secretary · British · appointed 1998-04-08 · resigned 2011-02-28
- BICKNELL, Simon Michael — secretary · British · resigned 1994-12-08
- BOLTON, Jonathan Mark — secretary · British · appointed 1997-08-15 · resigned 1998-04-08
- CHRISTIAN, Christopher Lindsay — secretary · British · appointed 1995-11-01 · resigned 1997-08-15
- HYDE, Jonathan Laurence Patrick — secretary · British · appointed 1994-12-08 · resigned 1995-10-31
- ADAM, Christopher — director · British · appointed 1994-02-16 · resigned 1995-01-26
- ALLEN, David George — director · British · appointed 2015-12-01 · resigned 2024-04-30
- ANDERSON, Jill Dawn — director · British · appointed 2023-03-01 · resigned 2024-06-25
- ANDO, Goran Albert Torstensson, Doctor — director · Swedish · resigned 1995-01-16
- ANDRIES, Jerome Charles Maurice — director · French · appointed 2018-04-12 · resigned 2023-03-01
- BAKER, Darrell — director · British · appointed 2010-07-01 · resigned 2013-02-18
- BAXTER, Allan, Dr — director · British · appointed 1995-01-19 · resigned 2010-06-30

### Beneficial owners (Persons with Significant Control)

- [Glaxo Group Limited](https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/00835139
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/00835139

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED** — https://whiteintel.dev/entity/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED**. Human view: https://whiteintel.dev/entity/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0 · Structured JSON: https://whiteintel.dev/api/public/dossier/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._